EMAIL THIS PAGE TO A FRIEND

International immunopharmacology

Keratinocyte nicotinic acetylcholine receptor activation modulates early TLR2-mediated wound healing responses.


PMID 26071220

Abstract

The cholinergic anti-inflammatory pathway spans several macro- and micro-environments to control inflammation via α7 nicotinic acetylcholine receptors (nAChRs). Physiologic inflammation is necessary for normal wound repair and is triggered, in part, via Toll-like receptors (TLRs). Here, we demonstrate that keratinocyte nAChR activation dampens TLR2-mediated migration and pro-inflammatory cytokine and antimicrobial peptide (AMP) production, which is restored by a α7-selective nAChR antagonist. The mechanism of this response occurs by blocking the NF-κB and Erk1/2 pathway during early and late wound healing. In a mouse model of Staphylococcus aureus wound infection, topical nAChR activation reduces wound AMP and TLR2 production to augment bacterial survival in wild-type mice. These findings suggest that aberrant α7 nAChR activation may impair normal wound healing responses, and that pharmacologic administration of topical nAChR antagonists may improve wound healing outcomes in wounds necessitating a more robust inflammatory response.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1400041
Anti-CAMP antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
HPA029874
Anti-CAMP antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
GW22787 Anti-TLR2 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
PRS3135
Anti-TLR2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
EHU081441 MISSION® esiRNA, esiRNA human MAPK14 (esiRNA1)
WH0007097M7
Monoclonal Anti-TLR2 antibody produced in mouse, clone 1E7, purified immunoglobulin, buffered aqueous solution
SAB1404474
Monoclonal Anti-TLR2 antibody produced in mouse, clone 2G9, purified immunoglobulin, buffered aqueous solution
SAB1409745
Monoclonal Anti-TLR2 antibody produced in mouse, clone 2A3, purified immunoglobulin, buffered aqueous solution
SAB1409746 Monoclonal Anti-TLR2 antibody produced in mouse, clone 2D2, purified immunoglobulin, buffered aqueous solution
SAB1409747 Monoclonal Anti-TLR2 antibody produced in mouse, clone 3F10, purified immunoglobulin, buffered aqueous solution
SAB1409748 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1E3, purified immunoglobulin, buffered aqueous solution
SAB1409749 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4D6, purified immunoglobulin, buffered aqueous solution
SAB1409750 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4G9, purified immunoglobulin, buffered aqueous solution
SAB1409751 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1C6, purified immunoglobulin, buffered aqueous solution
SAB1409752 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1B10, purified immunoglobulin, buffered aqueous solution
SAB1409753 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4C4, purified immunoglobulin, buffered aqueous solution
SAB1409754 Monoclonal Anti-TLR2 antibody produced in mouse, clone 3H8, purified immunoglobulin, buffered aqueous solution
SAB1409755 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4H6, purified immunoglobulin, buffered aqueous solution